Sequel Pharmaceuticals
Sequel Pharmaceuticals, Inc.: A US-based company developing clinical-stage drugs for cardiovascular diseases.
Founded
2007Sequel Pharmaceuticals, Inc.: A US-based company developing clinical-stage drugs for cardiovascular diseases.
Sequel Pharmaceuticals, Inc., founded in the United States, is a privately held specialty pharmaceutical company focused on developing clinical-stage drug candidates for cardiovascular diseases. The company's core mission is to address unmet medical needs in select therapeutic areas by acquiring, developing, and marketing innovative medical drugs. Sequel Pharmaceuticals aims to improve patient outcomes through its targeted approach in the cardiovascular sector.
Notable affiliated individuals include key figures in the pharmaceutical industry who bring extensive experience in drug development and commercialization. The company has garnered attention from investors interested in high-impact medical innovations. Sequel Pharmaceuticals' key achievements include advancing several drug candidates to clinical stages, demonstrating potential efficacy in treating cardiovascular conditions. The company's overall impact lies in its commitment to pioneering treatments that could significantly enhance the quality of life for patients with cardiovascular diseases.
Companies similar to Sequel Pharmaceuticals include Sequella, Cardurion Pharmaceuticals, Corridor Pharmaceuticals and Anexon.
Sequel Pharmaceuticals was founded in 2007.
Sequel Pharmaceuticals' headquarters is located in San Diego, CA, US.
Sequel Pharmaceuticals' most recent funding round was for $1M (USD) in December 2010.
As of Dec 22, 2010, Sequel Pharmaceuticals has raised a total of $25.4M (USD).
Sequel Pharmaceuticals has 30 employees as of Feb 5, 2024.
